Gene polymorphisms and susceptibility to psychopathology in patients with metastatic carcinoid disease

Gene polymorphisms and susceptibility to psychopathology in patients with metastatic carcinoid disease - Gene polymorphisms and psychopathology

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30789

Enrollment

150

Registered

2007-02-13

Start date

2007-04-27

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carcinoid tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a proven carcinoïd syndrome, in who plasma tryptophan and urinary 5-HIAA levels are recently determined

Exclusion criteria

Exclusion criteria: Patients who, after being informed about the study, are not willing to participate.

Design outcomes

Primary

Measure	Time frame
- Biochemical data serotonin metabolism - Gene polymorphisms - Outcome questionnaires Primary outcome: the relationship between certain gene polymorphisms and psychiatric symptomatology.	—

Secondary

Measure	Time frame
no	—

Countries

Netherlands

Outcome results